The Carpentier-Edwards Perimount Magna mitral valve bioprosthesis: intermediate-term efficacy and durability.

about

The Carpentier-Edwards Perimount Magna mitral valve bioprosthesis: intermediate-term efficacy and durability.

Item

http://www.wikidata.org/entity/Q36507903

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

The Carpentier-Edwards Perimou ...... -term efficacy and durability.

@ast

The Carpentier-Edwards Perimou ...... -term efficacy and durability.

@en

type

Item

label

The Carpentier-Edwards Perimou ...... -term efficacy and durability.

@ast

The Carpentier-Edwards Perimou ...... -term efficacy and durability.

@en

prefLabel

The Carpentier-Edwards Perimou ...... -term efficacy and durability.

@ast

The Carpentier-Edwards Perimou ...... -term efficacy and durability.

@en

P1476

The Carpentier-Edwards Perimou ...... -term efficacy and durability.

@en

P2093

Aldo Rafael

http://www.w3.org/2001/XMLSchema#string

Andres Schuster

http://www.w3.org/2001/XMLSchema#string

Gabriel Loor

http://www.w3.org/2001/XMLSchema#string

James Diaz

http://www.w3.org/2001/XMLSchema#string

Kenneth McCurry

http://www.w3.org/2001/XMLSchema#string

Vincent Cruz

http://www.w3.org/2001/XMLSchema#string

William J Stewart

http://www.w3.org/2001/XMLSchema#string

P2860

Mitral-valve repair versus replacement for severe ischemic mitral regurgitation.

Mitral valve replacement with preservation of the subvalvular apparatus.

2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Commit

Reoperative mitral valve replacement: importance of preservation of the subvalvular apparatus.

Impact of preoperative atrial fibrillation on mortality and cardiovascular outcomes of mechanical mitral valve replacement for rheumatic mitral valve disease.

Twenty-year experience with the St. Jude medical Biocor bioprosthesis in the aortic position.

Mitral replacement or repair for functional mitral regurgitation in dilated and ischemic cardiomyopathy: is it really the same?

Repair versus replacement for degenerative mitral valve disease with coexisting ischemic heart disease.

Very long-term survival implications of heart valve replacement with tissue versus mechanical prostheses in adults <60 years of age.

Mechanical versus bioprosthetic valve replacement in middle-aged patients.

P2888

s13019-016-0412-4

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13019-016-0412-4

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

292072419

http://www.w3.org/2001/XMLSchema#string

P6179

1014701277

http://www.w3.org/2001/XMLSchema#string

P698

26818795

http://www.w3.org/2001/XMLSchema#string

P932

4728780

http://www.w3.org/2001/XMLSchema#string